Clinical Trial Update: COmpliance and Efficacy in Mono and Combination Tablet Study ATacand/Atacand Plus

View source ↗

Summary

A completed clinical trial evaluated the compliance and efficacy of candesartan as monotherapy and in the Atacand Plus combination tablet for hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Atacand (candesartan)
• Atacand Plus

Snippet

Sponsor: AstraZeneca | Conditions: Hypertension | Status: COMPLETED